ω-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization

Patent metadata

Field	Value
Publication number	US-10066043-B2
Application number	US-201715428063-A
Country	US
Kind code	B2
Filing date	Feb 8, 2017
Priority date	Dec 8, 2008
Publication date	Sep 4, 2018
Grant date	Sep 4, 2018

Abstract

Polymeric compounds having spatially controlled bioconjugation sites are described. Functionalization is achieved by selective ω-terminal chain extension of polymer chains by radical polymerization, such as reversible addition-fragmentation chain transfer (RAFT) polymerization.

First claim

The invention claimed is:

1. A method for preparing a polymer, the method comprising:
(a) providing a macromolecular chain transfer agent having a formula P n —Y, wherein P n is a first polymer chain, Y is a chain transfer residue having a formula SC(═S)Z, and Z is an activating group, and
(b) reacting a chain extension monomer and the macromolecular chain transfer agent under reversible addition-fragmentation chain transfer (RAFT) chain extension conditions to form a polymer having a formula P n -(E) k -Y, wherein k is an integer ranging from 1 to 20, and wherein chain extension residue E has a formula E3

wherein
R 1 and R 4 are each hydrogen,
R 2 , N—R 5 , and R 3 , together form an N-substituted imidyl moiety represented by the formula —C(O)NR 5 C(O)—, and
R 5 is a C 1 -C 20 moiety comprising (i) a functional group or (ii) a functional group covalently coupled to a biomolecular agent through a linking moiety, wherein the C 1 -C 20 moiety is selected from the group consisting of hydrocarbyl, substituted hydrocarbyl, hetero-hydrocarbyl, substituted hetero-hydrocarbyl, carbocyclic, substituted carbocyclic, heterocyclic, substituted heterocyclic, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and fused-multiring structures comprising one or more of the foregoing, and wherein the functional group is selected from the group consisting of amino, ammonio, imino, amido, imidyl, nitrile, azo, azido, cyano, cyanato, isocyanato, isothiocyanto, hydrazide, nitro, nitroso, nitrosooxy, pyridyl, hydroxyl, alkoxy, carboxyl, ester, acyl, halo, haloformyl, phosphino, phosphoric, phospho, sulfide, disulfide, thio, thiol, sulfonyl, sulfo, sulfinyl, alkenyl, alkynl, allenyl, and silyl.

2. The method of claim 1 , further comprising
(c) reacting a set of one or more monomers and the polymer of formula P n -(E) k -Y under RAFT polymerization conditions to form a polymer having a formula P n -(E) k -P m —Y, wherein P m is a second polymer chain.

3. The method of claim 1 , further comprising preparing the macromolecular chain transfer agent of formula P n —Y before step (a).

4. The method of claim 3 , wherein preparing the macromolecular chain transfer agent comprises reacting a first set A of one or more monomers and a chain transfer agent comprising a thio-carbonyl-thio moiety under RAFT polymerization conditions.

5. The method of claim 4 , further comprising
(c) reacting a second set B of one or more monomers and the polymer of formula P n -(E) k -Y under RAFT polymerization conditions to form a polymer having a formula P n -(E) k -P m —Y, wherein P m is a second polymer chain.

6. The method of claim 5 , wherein the second set B of one or more monomers is different from the first set A of one or more monomers.

7. The method of claim 1 , further comprising cleaving the chain transfer residue Y to yield a chain transfer residue derivative, Y*.

8. The method of claim 7 , wherein Y* is selected from the group consisting of hydrogen and —SH.

9. The method of claim 1 , wherein k is an integer ranging from 1 to 10.

10. The method of claim 9 , wherein each of the macromolecular chain transfer agent and the polymer of formula P n -(E) k -Y has a polydispersity index, M w /M n , of less than 1.5, and wherein the polydispersity index of the polymer of formula P n -(E) k -Y differs from the polydispersity index of the macromolecular chain transfer agent by not more than 10%.

11. The method of claim 10 , wherein the polydispersity index of the polymer of formula P n -(E) k -Y differs from the polydispersity index of the macromolecular chain transfer agent by not more than 5%.

12. The method of claim 1 , wherein R 5 comprises (ii) the functional group covalently coupled to the biomolecular agent through the linking moiety.

13. The method of claim 12 , wherein the biomolecular agent is selected from the group consisting of a therapeutic agent and a targeting moiety.

14. The method of claim 12 , wherein the biomolecular agent is selected from the group consisting of a polynucleic acid, a polyamino acid, a polysaccharide, and a small molecule.

15. A method for preparing a polymer, the method comprising:
(a) providing a macromolecular chain transfer agent having a formula P n —Y, wherein P n is a first polymer chain, Y is a chain transfer residue having a formula SC(═S)Z, and Z is an activating group, and
(b) reacting a chain extension monomer and the macromolecular chain transfer agent under reversible addition-fragmentation chain transfer (RAFT) chain extension conditions to form a polymer having a formula P n -(E) k -Y, wherein k is an integer ranging from 1 to 20, and wherein chain extension residue E has a formula E3

wherein
R 1 and R 4 are each hydrogen,
R 2 , N-R 5 , and R 3 , together form an N-substituted imidyl moiety represented by the formula —C(O)NR 5 C(O)—, and
R 5 is a C 1 -C 20 moiety comprising a primary or secondary amine, wherein the C 1 -C 20 moiety is selected from the group consisting of hydrocarbyl, substituted hydrocarbyl, hetero-hydrocarbyl, substituted hetero-hydrocarbyl, carbocyclic, substituted carbocyclic, heterocyclic, substituted heterocyclic, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and fused-multi-ring structures comprising one or more of the foregoing, and
(c) conjugating a biomolecular agent to the polymer of formula P n -(E) k -Y utilizing the primary or secondary amine.

16. The method of claim 15 , wherein the biomolecular agent is selected from the group consisting of a therapeutic agent and a targeting moiety.

17. The method of claim 15 , wherein the biomolecular agent is selected from the group consisting of a polynucleic acid, a polyamino acid, a polysaccharide, and a small molecule.

Assignees

• Univ Washington
• Phaserx Inc

Inventors

• Stayton Patrick S
• Hoffman Allan S
• Convertine Anthony J
• Henry Scott M
• Overell Robert W
• Johnson Paul H

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• C12N15/111

  General methods applicable to biologically active non-coding nucleic acids · CPC title

• C08F220/54

  Amides {, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide} · CPC title

• C08F293/005 Primary

  using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent · CPC title

• C08F2438/03

  Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX] · CPC title